Exceptional Response of Refractory Atll With Mdm4 Amplification to Novel Stapled Peptide Dual Mdm4/2 Inhibitor

Hematological Oncology - United Kingdom
doi 10.1002/hon.210_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Dimethylbromobenzene-Cysteine Stapled Peptide Dual Inhibitor of the P53-Mdm2/MDMX Interactions

Hepatoma Research
2019English

Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and Development

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2007English

Mutual Regulation of MDM4 and TOP2A in Cancer Cell Proliferation

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Inhibition of MDMX (Mdm4) in Vivo Induces Anti-Obesity Effects

Oncotarget
Oncology
2018English

Modifying Effect of MDM4 Variants on Risk of HPV16-associated Squamous Cell Carcinoma of Oropharynx

Cancer
Cancer ResearchOncology
2011English

MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

Cancer Research
Cancer ResearchOncology
2019English

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

Cancers
Cancer ResearchOncology
2020English

P1.13-28 the Functional MDM4 Genetic Polymorphsim as Prognostic Biomarker for Advanced Lung Adenocarcinoma Patients' Survival to EGFR-TKIs Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Solution Structure of a Hydrocarbon Stapled Peptide Inhibitor in Complex With Monomeric C-Terminal Domain of HIV-1 Capsid

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy